Ceigall India Share Price in Focus; Receives ₹225 Crore Order for Una Bulk Drug Park Project

Ceigall India Limited has received a ₹225 crore order from Himachal Pradesh State Industrial Development Corporation Limited (HPSIDC). The value includes GST, according to a regulatory filing made by the company on 21 August 2026. 

The contract is for the development of a Bulk Drug Park in Una in Himachal Pradesh. Ceigall received the Letter of Award from HPSIDC by email on 20 August 2026. 

Work to Be Completed in 18 Months 

The project has been awarded for an execution period of 18 months. It is an item-rate contract, with performance security set at 3% of the contract value. 

The first phase of the project will involve formation cutting and the construction of internal roads, storm water drains, a bridge, and fencing. 

Domestic Contract 

HPSIDC is the entity that awarded the order, and Ceigall has classified the contract as being awarded by a domestic entity. 

The company noted that its promoters, promoter group, and group companies have no interest in HPSIDC. It also stated that the order does not fall under related-party transactions. 

Ceigall’s Project Portfolio 

Ceigall India operates in the infrastructure engineering, procurement and construction business. Its work includes highways, expressways, bridges, flyovers, railway overbridges, tunnels, and runways. 

The company undertakes projects through EPC and Hybrid Annuity Model formats and has projects across multiple states. 

Read More: Vedanta Aluminium Share Price Surges; Launches Advanced Metals for Automotive Industry! 

Ceigall India Limited Share Price Performance 

As of August 21, 2026, 1:55 pm, Ceigall India share price was trading at ₹314.00, a 0.38% increase from the previous closing price. 

Conclusion 

The ₹225 crore order relates to infrastructure work for the Bulk Drug Park at Una. The project is scheduled for completion within 18 months. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.